In a filing, Abeona Therapeutics Inc revealed its Chief Executive Officer Seshadri Vishwas unloaded Company’s shares for reported $0.12 million on Mar 31 ’25. In the deal valued at $4.78 per share,25,000 shares were sold. As a result of this transaction, Seshadri Vishwas now holds 1,355,322 shares worth roughly $5.85 million.
Then, Seshadri Vishwas bought 25,000 shares, generating $119,560 in total proceeds.
Before that, Alvino Mark sold 4,000 shares. Abeona Therapeutics Inc shares valued at $21,520 were divested by the Director at a price of $5.38 per share. As a result of the transaction, Alvino Mark now holds 64,334 shares, worth roughly $0.28 million.
Oppenheimer initiated its Abeona Therapeutics Inc [ABEO] rating to an Outperform in a research note published on March 05, 2025; the price target was $16. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Stifel began covering ABEO with “Buy” recommendation on May 30, 2024. Cantor Fitzgerald revised its rating on November 11, 2020. It rated ABEO as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of ABEO
On Tuesday, Abeona Therapeutics Inc [NASDAQ:ABEO] saw its stock fall -4.11% to $4.32. Over the last five days, the stock has lost -2.92%. Abeona Therapeutics Inc shares have fallen nearly -22.44% since the year began. Nevertheless, the stocks have fallen -41.94% over the past one year. While a 52-week high of $8.45 was reached on 02/14/25, a 52-week low of $3.05 was recorded on 04/08/25. SMA at 50 days reached $5.31, while 200 days put it at $5.54.
Levels Of Support And Resistance For ABEO Stock
The 24-hour chart illustrates a support level at 4.11, which if violated will result in even more drops to 3.89. On the upside, there is a resistance level at 4.69. A further resistance level may holdings at 5.05. The Relative Strength Index (RSI) on the 14-day chart is 33.00, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.38, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.78%. Stochastics %K at 12.80% indicates the stock is a buying.
How much short interest is there in Abeona Therapeutics Inc?
A steep rise in short interest was recorded in Abeona Therapeutics Inc stocks on 2025-03-14, dropping by 79753.0 shares to a total of 2.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 2.47 million shares. There was a decline of -3.34%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 18, 2020 when B. Riley FBR began covering the stock and recommended ‘”a Buy”‘ rating along with a $5 price target.
